17.08.2013 10:10:19
|
Merck Temporarily Suspends Sales Of Zilmax
(RTTNews) - Healthcare giant Merck & Co., Inc. (MRK), Friday said it temporarily suspended sales of Zilmax, an FDA-approved supplement for cattle, in the United States and Canada. Media reports quoted that the cattle had trouble standing or walking after taking Zilmax. The supplement which has been used by farmers for almost two decades,improves the cattle's natural ability to convert feed into more lean beef. Zilmax had sales of $159 million in the United States and Canada in 2012.
The New Jersey based firm said as announced previously it will monitor the process of feeding of Zilmax, and review the factors such as nutrition, transportation and receiving facilities. Merck, however, said that it has stopped the sales of Zilmax temporarily to ensure effective implementation of its five-step plan to making responsible beef.
Commenting on the temporary suspension of sales and five-step plan, Varma, Senior Vice President Global R&D said: "...This important step demonstrates our commitment to providing our industry partners with data that will reaffirm confidence in Zilmax. We sincerely regret that this situation creates business challenges for our customers but it is critical to ensure that this process is conducted appropriately and with rigorous scientific measures. After the five-step plan is completed, the results will be shared publicly."
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck Co.mehr Nachrichten
31.12.24 |
Minuszeichen in New York: Dow Jones zum Handelsende leichter (finanzen.at) | |
31.12.24 |
Handel in New York: Dow Jones legt am Nachmittag den Rückwärtsgang ein (finanzen.at) | |
31.12.24 |
Dow Jones-Handel aktuell: Dow Jones zeigt sich schwächer (finanzen.at) | |
31.12.24 |
Dow Jones 30 Industrial-Titel Merck-Aktie: So viel hätten Anleger mit einem Investment in Merck von vor 3 Jahren verdient (finanzen.at) | |
31.12.24 |
Dow Jones-Handel aktuell: Dow Jones zum Start des Dienstagshandels mit Zuschlägen (finanzen.at) | |
30.12.24 |
Montagshandel in New York: Dow Jones verbucht zum Ende des Montagshandels Verluste (finanzen.at) | |
27.12.24 |
Zurückhaltung in New York: Dow Jones notiert zum Handelsende im Minus (finanzen.at) | |
27.12.24 |
Börse New York in Rot: Dow Jones verliert zum Start (finanzen.at) |
Analysen zu Merck Co.mehr Analysen
Aktien in diesem Artikel
Merck Co. | 96,00 | -0,41% |